Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines"

J Immunol. 2024 Mar 1;212(5):753. doi: 10.4049/jimmunol.2300425.

Author

Abraham Al-Ahmad¹

Affiliation

¹ Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX; and Center for Blood-Brain Barrier Research, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX.

PMID: 38377475
DOI: 10.4049/jimmunol.2300425

No abstract available

MeSH terms

Antibodies
BNT162 Vaccine
COVID-19* / prevention & control
Exosomes*
Humans
Spike Glycoprotein, Coronavirus / genetics
Vaccination
mRNA Vaccines

Substances

BNT162 Vaccine
mRNA Vaccines
spike protein, SARS-CoV-2
Spike Glycoprotein, Coronavirus
Antibodies

Grants and funding